Coverart for item
The Resource Cancer chemotherapy and biotherapy : principles and practice, editors Bruce A. Chabner, Dan L. Longo

Cancer chemotherapy and biotherapy : principles and practice, editors Bruce A. Chabner, Dan L. Longo

Label
Cancer chemotherapy and biotherapy : principles and practice
Title
Cancer chemotherapy and biotherapy
Title remainder
principles and practice
Statement of responsibility
editors Bruce A. Chabner, Dan L. Longo
Contributor
Subject
Language
eng
Cataloging source
DNLM/DLC
Illustrations
illustrations
Index
index present
Literary form
non fiction
Nature of contents
bibliography
http://library.link/vocab/relatedWorkOrContributorDate
1949-
http://library.link/vocab/relatedWorkOrContributorName
  • Chabner, Bruce A
  • Longo, Dan Louis
http://library.link/vocab/subjectName
  • Cancer
  • Cancer
  • Antineoplastic agents
  • Biological response modifiers
  • Neoplasms
  • Antineoplastic Agents
  • Biological Products
Label
Cancer chemotherapy and biotherapy : principles and practice, editors Bruce A. Chabner, Dan L. Longo
Instantiates
Publication
Bibliography note
Includes bibliographical references and index
Contents
  • 1.
  • Clinical strategies for cancer treatment : the role of drugs/
  • Bruce A. Chabner
  • p. 1
  • Edward A. Sausville
  • p. 15
  • 2.
  • Preclinical aspects of cancer drug discovery and development/
  • Paula Krosky
  • Melinda Hollingshead
  • Robert Shoemaker
  • 3.
  • Pharmacokinetics/
  • Jerry Collins
  • Jeffrey G. Supko
  • p. 31
  • 4.
  • Infertility after cancer chemotherapy/
  • Angela Bradbury
  • Richard L. Schilsky
  • p. 45
  • 5.
  • Carcinogenesis of anticancer drugs/
  • Lawrence S. Blaszkowsky
  • Charles Erlichman
  • p. 70
  • 6.
  • Antifolates/
  • Brian P. Monahan
  • Carmen J. Allegra
  • p. 91
  • 7.
  • 5-fluoropyrimidines/
  • Jean L. Grem
  • p. 125
  • p. 183
  • 8.
  • Cytidine analogues/
  • David P. Ryan
  • Rocio Garcia-Carbonero
  • Bruce A. Chabner
  • 9.
  • Purine antimetabolites/
  • Kenneth R. Hande
  • p. 212
  • p. 229
  • 10.
  • Hydroxyurea/
  • Luis Paz-Ares
  • Ross C. Donehower
  • Bruce A. Chabner
  • 11.
  • Antimicrotubule agents/
  • Eric K. Rowinsky
  • p. 237
  • p. 283
  • 12.
  • Clinical and high-dose alkylating agents/
  • Kenneth D. Tew
  • O. Michael Colvin
  • Roy B. Jones
  • p. 310
  • 13.
  • Nonclassic agents/
  • Henry S. Friedman
  • Steven D. Averbuch
  • Joanne Kurtzberg
  • 14.
  • Cisplatin, carboplatin, and oxaliplatin/
  • Eddie Reed
  • p. 332
  • 15.
  • Bleomycin/
  • John S. Lazo
  • Bruce A. Chabner
  • p. 344
  • p. 359
  • 16.
  • Antitumor antibiotics/
  • Edwin W. Willems
  • Kees Nooter
  • Jaap Verweij
  • 17.
  • Topoisomerase I-targeting drugs/
  • Alex Sparreboom
  • William C. Zamboni
  • p. 371
  • 18.
  • Anthracyclines and anthracenediones/
  • James H. Doroshow
  • p. 414
  • 19.
  • Topoisomerase II inhibitors : the epipodophyllotoxins, acridines, and ellipticines/
  • Yves Pommier
  • Francois Goldwasser
  • p. 451
  • 20.
  • Asparaginase/
  • Bruce A. Chabner
  • Alison M. Friedmann
  • p. 476
  • p. 484
  • 21.
  • Delivering anticancer drugs to brain tumors/
  • Maciej M. Mrugala
  • Tracy T. Batchelor
  • Jeffrey C. Supko
  • 22.
  • Food and drug administration role in oncology product development/
  • Thomas G. Roberts, Jr.
  • p. 502
  • 23.
  • Central venous catheters : care and complications/
  • Rachel P. Rosovsky
  • David J. Kuter
  • p. 516
  • 24.
  • Pharmacogenetics/
  • Jeanne Fourie
  • Robert B. Diasio
  • p. 529
  • S. Percy Ivy
  • Len Neckers
  • Bennett Kaufman
  • Richard Swerdlow
  • p. 549
  • 25.
  • New targets for anticancer therapeutics/
  • A. Dimitrios Colevas
  • Orit Scharf
  • Janet E. Dancey
  • 26.
  • Bisphosphonates/
  • Matthew R. Smith
  • p. 579
  • Kenneth Anderson
  • p. 587
  • 27.
  • Thalidomide and its analogs for the treatment of hematologic malignancies, including multiple myeloma, and solid tumors/
  • Paul Richardson
  • Constantine S. Mitsiades
  • Teru Hideshima
  • 28.
  • Inhibitors of tumor angiogenesis/
  • Anaadriana Zakarija
  • William I. Gradishar
  • p. 605
  • 29.
  • Proteasome inhibitors/
  • Owen A. O'Connor
  • p. 621
  • 30.
  • Molecular targeted drugs and growth factor receptor inhibitors/
  • Jeffrey W. Clark
  • p. 641
  • Richard P. Junghans
  • George Sgouros
  • p. 666
  • 31.
  • Antibody therapies of cancer/
  • David A. Scheinberg
  • Deborah A. Mulford
  • Joseph G. Juric
  • Paul A. Masci
  • Ernest C. Borden
  • p. 699
  • 32.
  • Interferons/
  • Daniel J. Lindner
  • Kevin L. Taylor
  • Frederic J. Reu
  • 33.
  • Adoptive cellular therapies/
  • Carl H. June
  • p. 718
  • 34.
  • Cancer vaccines/
  • Glenn Dranoff
  • p. 739
  • 35.
  • Hematopoietic growth factors/
  • William P. Petros
  • p. 747
  • James H. Finke
  • p. 767
  • 36.
  • Interleukins/
  • Gheath Alatrash
  • Ronald M. Bukowski
  • Charles S. Tannenbaum
  • 37.
  • Hormonal therapy for breast cancer/
  • Peter F. Lebowitz
  • Sandra M. Swain
  • p. 809
Control code
ocm61285522
Dimensions
29 cm.
Edition
4th ed.
Extent
xv, 879 p.
Isbn
9780781756280
Lccn
2005022888
Other physical details
ill. (some col.)
Label
Cancer chemotherapy and biotherapy : principles and practice, editors Bruce A. Chabner, Dan L. Longo
Publication
Bibliography note
Includes bibliographical references and index
Contents
  • 1.
  • Clinical strategies for cancer treatment : the role of drugs/
  • Bruce A. Chabner
  • p. 1
  • Edward A. Sausville
  • p. 15
  • 2.
  • Preclinical aspects of cancer drug discovery and development/
  • Paula Krosky
  • Melinda Hollingshead
  • Robert Shoemaker
  • 3.
  • Pharmacokinetics/
  • Jerry Collins
  • Jeffrey G. Supko
  • p. 31
  • 4.
  • Infertility after cancer chemotherapy/
  • Angela Bradbury
  • Richard L. Schilsky
  • p. 45
  • 5.
  • Carcinogenesis of anticancer drugs/
  • Lawrence S. Blaszkowsky
  • Charles Erlichman
  • p. 70
  • 6.
  • Antifolates/
  • Brian P. Monahan
  • Carmen J. Allegra
  • p. 91
  • 7.
  • 5-fluoropyrimidines/
  • Jean L. Grem
  • p. 125
  • p. 183
  • 8.
  • Cytidine analogues/
  • David P. Ryan
  • Rocio Garcia-Carbonero
  • Bruce A. Chabner
  • 9.
  • Purine antimetabolites/
  • Kenneth R. Hande
  • p. 212
  • p. 229
  • 10.
  • Hydroxyurea/
  • Luis Paz-Ares
  • Ross C. Donehower
  • Bruce A. Chabner
  • 11.
  • Antimicrotubule agents/
  • Eric K. Rowinsky
  • p. 237
  • p. 283
  • 12.
  • Clinical and high-dose alkylating agents/
  • Kenneth D. Tew
  • O. Michael Colvin
  • Roy B. Jones
  • p. 310
  • 13.
  • Nonclassic agents/
  • Henry S. Friedman
  • Steven D. Averbuch
  • Joanne Kurtzberg
  • 14.
  • Cisplatin, carboplatin, and oxaliplatin/
  • Eddie Reed
  • p. 332
  • 15.
  • Bleomycin/
  • John S. Lazo
  • Bruce A. Chabner
  • p. 344
  • p. 359
  • 16.
  • Antitumor antibiotics/
  • Edwin W. Willems
  • Kees Nooter
  • Jaap Verweij
  • 17.
  • Topoisomerase I-targeting drugs/
  • Alex Sparreboom
  • William C. Zamboni
  • p. 371
  • 18.
  • Anthracyclines and anthracenediones/
  • James H. Doroshow
  • p. 414
  • 19.
  • Topoisomerase II inhibitors : the epipodophyllotoxins, acridines, and ellipticines/
  • Yves Pommier
  • Francois Goldwasser
  • p. 451
  • 20.
  • Asparaginase/
  • Bruce A. Chabner
  • Alison M. Friedmann
  • p. 476
  • p. 484
  • 21.
  • Delivering anticancer drugs to brain tumors/
  • Maciej M. Mrugala
  • Tracy T. Batchelor
  • Jeffrey C. Supko
  • 22.
  • Food and drug administration role in oncology product development/
  • Thomas G. Roberts, Jr.
  • p. 502
  • 23.
  • Central venous catheters : care and complications/
  • Rachel P. Rosovsky
  • David J. Kuter
  • p. 516
  • 24.
  • Pharmacogenetics/
  • Jeanne Fourie
  • Robert B. Diasio
  • p. 529
  • S. Percy Ivy
  • Len Neckers
  • Bennett Kaufman
  • Richard Swerdlow
  • p. 549
  • 25.
  • New targets for anticancer therapeutics/
  • A. Dimitrios Colevas
  • Orit Scharf
  • Janet E. Dancey
  • 26.
  • Bisphosphonates/
  • Matthew R. Smith
  • p. 579
  • Kenneth Anderson
  • p. 587
  • 27.
  • Thalidomide and its analogs for the treatment of hematologic malignancies, including multiple myeloma, and solid tumors/
  • Paul Richardson
  • Constantine S. Mitsiades
  • Teru Hideshima
  • 28.
  • Inhibitors of tumor angiogenesis/
  • Anaadriana Zakarija
  • William I. Gradishar
  • p. 605
  • 29.
  • Proteasome inhibitors/
  • Owen A. O'Connor
  • p. 621
  • 30.
  • Molecular targeted drugs and growth factor receptor inhibitors/
  • Jeffrey W. Clark
  • p. 641
  • Richard P. Junghans
  • George Sgouros
  • p. 666
  • 31.
  • Antibody therapies of cancer/
  • David A. Scheinberg
  • Deborah A. Mulford
  • Joseph G. Juric
  • Paul A. Masci
  • Ernest C. Borden
  • p. 699
  • 32.
  • Interferons/
  • Daniel J. Lindner
  • Kevin L. Taylor
  • Frederic J. Reu
  • 33.
  • Adoptive cellular therapies/
  • Carl H. June
  • p. 718
  • 34.
  • Cancer vaccines/
  • Glenn Dranoff
  • p. 739
  • 35.
  • Hematopoietic growth factors/
  • William P. Petros
  • p. 747
  • James H. Finke
  • p. 767
  • 36.
  • Interleukins/
  • Gheath Alatrash
  • Ronald M. Bukowski
  • Charles S. Tannenbaum
  • 37.
  • Hormonal therapy for breast cancer/
  • Peter F. Lebowitz
  • Sandra M. Swain
  • p. 809
Control code
ocm61285522
Dimensions
29 cm.
Edition
4th ed.
Extent
xv, 879 p.
Isbn
9780781756280
Lccn
2005022888
Other physical details
ill. (some col.)

Library Locations

    • Leahurst Campus LibraryBorrow it
      Chester High Road, Neston, CH64 7TE, GB
      53.294668 -3.027523
Processing Feedback ...